Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center

被引：30

作者：

Borogovac, Azra ^{[1
]}

Keruakous, Amany ^{[1
,2
]}

Bycko, Michelle ^{[1
]}

Holter Chakrabarty, Jennifer ^{[1
]}

Ibrahimi, Sami ^{[1
]}

Khawandanah, Mohamad ^{[1
]}

Selby, George B. ^{[1
]}

Yuen, Carrie ^{[1
]}

Schmidt, Sarah ^{[1
]}

Autry, Marcus T. ^{[1
]}

Al-Juhaishi, Taha ^{[1
]}

Wieduwilt, Matthew J. ^{[1
]}

Asch, Adam S. ^{[1
]}

机构：

[1] Univ Oklahoma, Hematol Oncol Sect, Dept Med, Hlth Sci Ctr, Oklahoma City, OK 73019 USA

[2] Univ Augusta, Hematol Oncol Sect, Dept Med, Augusta, GA USA

来源：

BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / 06期

关键词：

D O I：

10.1038/s41409-022-01664-z

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

下载

页码：1025 / 1027

页数：3

共 50 条

[31] Polatuzumab Vedotin Use before Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Aggressive Lymphoma: A US Single Center Experience
Khurana, Arushi
Bansal, Radhika
Hathcock, Matthew
Nedved, Adrienne
Wang, Yucai
Paludo, Jonas
Villasboas, Jose C.
Bennani, N. Nora
Johnston, Patrick B.
Ansell, Stephen M.
Lin, Yi
BLOOD, 2021, 138 : 3842 - +
[32] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
Kampouri, Eleftheria
Little, Jessica S.
Rejeski, Kai
Manuel, Oriol
Hammond, Sarah P.
Hill, Joshua A.
TRANSPLANT INFECTIOUS DISEASE, 2023, 25
[33] MANAGEMENT OF COAGULOPATHY ASSOCIATED WITH TISAGENLECLEUCEL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY
Buechner, Jochen
Grupp, Stephan A.
Maude, Shannon L.
Hiramatsu, Hidefumi
Teachey, David
Wood, Patricia
Awasthi, Rakesh
Yi, Lan
De Moerloose, Barbara
PEDIATRIC BLOOD & CANCER, 2018, 65
[34] Side-effect management of chimeric antigen receptor (CAR) T-cell therapy
Schubert, M-L
Schmitt, M.
Wang, L.
Ramos, C. A.
Jordan, K.
Mueller-Tidow, C.
Dreger, P.
ANNALS OF ONCOLOGY, 2021, 32 (01) : 34 - 48
[35] Chimeric Antigen Receptor (CAR) T-cell therapy; a promising outlook for refractory malignancies
Haider, Syed Ali
Tariq, Syed Maaz
Hasan, Mohammad
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2018, 68 (09) : 1422 - 1423
[36] Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy
Ryan D. Salinas
Joseph S. Durgin
Donald M. O’Rourke
CNS Drugs, 2020, 34 : 127 - 145
[37] Cardiac effects of chimeric antigen receptor (CAR) T-cell therapy in children.
Burstein, Danielle S.
Maude, Shannon L.
Grupp, Stephan A.
Griffis, Heather
Rossano, Joseph W.
Lin, Kimberly Y.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[38] Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses
Riedell, Peter A.
Wu, Meng
Collins, Jennifer M.
Gideon, Jacklyn M.
Jakubowiak, Andrzej J.
Kline, Justin P.
Kosuri, Satyajit
Liu, Hongtao
Smith, Sonali M.
Bishop, Michael R.
LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1497 - 1501
[39] CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR ASPERGILLOSIS
Kumar, P.
Wurster, S.
daSilva, T.
Hauser, P.
Neelapu, S. S.
Kontoyiannis, D.
CYTOTHERAPY, 2024, 26 (06) : S10 - S11
[40] Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma
Feldman, Lisa
Brown, Christine
Badie, Behnam
NEUROMOLECULAR MEDICINE, 2022, 24 (01) : 35 - 40

← 1 2 3 4 5 →